Experimental evidence shows that circ-1073 binds to HuR in BC cells, increasing the levels of caspases 3/9 and E-cadherin, thereby inhibiting oncogenic activity (Yi et al., 2020). The gene discussed is ELAVL1; the disease is breast cancer.